Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121108
Status:
COMPLETED
Last Update Posted:
2022-01-05
First Post:
2005-07-13
Brief Title:
MEDI-524 Motavizumab for the Prevention of Respiratory Sycytial Virus RSV Disease Among Native American Indian Infants in the Southwestern United States
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Healthy |
Keywords:
| Name | View |
|---|---|
| RSV infants Native American Indians | View |